Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial (Q40050396)
Jump to navigation
Jump to search
scientific article published on 5 September 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial |
scientific article published on 5 September 2017 |
Statements
1 reference
Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial (English)
1 reference
Angela Maria Ruiz-Sternberg
0 references
Suzanne M Garland
1 reference
Jack Cuzick
1 reference
Warner K Huh
1 reference
Elmar A Joura
1 reference
Anna R Giuliano
1 reference
Ole-Erik Iversen
1 reference
Rosires Pereira de Andrade
1 reference
Kevin A Ault
1 reference
Deborah Bartholomew
1 reference
Ramon M Cestero
1 reference
Edison N Fedrizzi
1 reference
Angelica L Hirschberg
1 reference
Marie-Hélène Mayrand
1 reference
Alex Ferenczy
1 reference
Robert Kurman
1 reference
Brigitte M Ronnett
1 reference
Mark H Stoler
1 reference
Susanne K Kjaer
1 reference
Oliver M Bautista
1 reference
Richard Haupt
1 reference
Erin Moeller
1 reference
Michael Ritter
1 reference
Christine Shields
1 reference
Alain Luxembourg
1 reference
5 September 2017
1 reference
1 reference
Identifiers
1 reference